Vertex Pharmaceuticals Inc. buy Guggenheim
Start price
06.08.25
/
50%
€329.95
Target price
06.08.26
€471.96
Performance (%)
16.75%
Price
12.12.25
€385.20
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 16.75%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Guggenheim for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Guggenheim from $558.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Guggenheim for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€453.20
02.08.24
02.08.24
€511.18
02.08.25
02.08.25
-11.90%
03.08.25
03.08.25
